Burleson Tess 4
4 · Salarius Pharmaceuticals, Inc. · Filed Feb 13, 2020
Insider Transaction Report
Form 4
Burleson Tess
Director
Transactions
- Purchase
Warrants (right to buy)
2020-02-11$0.01/sh+4,350$44→ 4,350 totalExercise: $1.15From: 2020-02-11Exp: 2025-02-11→ Common Stock (4,350 underlying)
Footnotes (1)
- [F1]The Reporting Person acquired these securities in the Issuer's public offering of Class A Units on February 11, 2020. Each Class A Unit consisted of one share of Common Stock and one warrant to purchase a single share of Common Stock.